Search
for
Sort by
Research 121–150 of 470
- Management of Cutaneous and Extracutaneous Side Effects of Smoothened Inhibitor Therapy for Advanced Basal Cell Carcinoma
- Skin diseases in consequence of endocrine alterations
- Safety of oral bicalutamide in female pattern hair loss: A retrospective review of 316 patients
- Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects
- Syphilitic Alopecia: A Report of 5 Cases and a Review of the Literature
- COVID-19 infection leading to acute pustular dermatoses
- Levodopa-induced skin disorders in patients with Parkinson disease: a systematic literature review approach
- Acne vulgaris
- Psychoactive drugs and skin
- Retinoids for Chemoprophylaxis of Nonmelanoma Skin Cancer
- CUTANEOUS T-CELL LYMPHOMA
- Immunomodulators in the treatment of cutaneous lymphoma
- Evaluation of the Tolerability of Hedgehog Pathway Inhibitors in the Treatment of Advanced Basal Cell Carcinoma: A Narrative Review of Treatment Strategies
- Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus
- Risk factors associated with development and persistence of long COVID
- Fixed-Drug Eruption due to Dextromethorphan
- Skin disorders associated with the COVID‐19 pandemic: A review
- Approach to Patients with Suspected Rheumatic Disease
- Drug safety evaluation of exemestane
- Risk of rhabdomyolysis from 5-α reductase inhibitors
- Indian Gooseberry (<i>Emblica officinalis</i>Gaertn.)
- Severe cardiac conduction abnormalities associated with atypical toxic shock syndrome
- Significance of iron status in hair loss in women
- The spectrum of nephrocutaneous diseases and associations
- Optimal Management of Plaque Psoriasis in Adolescents: Current Perspectives
- Adipose tissue transplant in recurrent folliculitis decalvans
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Acne
- Adverse events associated with vismodegib: insights from a real-world pharmacovigilance study using the FAERS database
- Monoclonal Antibody Against Prolactin Receptor: A Randomized Placebo-Controlled Study Evaluating Safety, Tolerability, and Pharmacokinetics of Repeated Subcutaneous Administrations in Postmenopausal Women